A stability-indicating high-performance thin-layer chromatographic method has been developed for the determination of terbutaline sulfate (TBS) as a bulk drug and in pharmaceutical formulations (submicronized dry powder inhalers). The separation was achieved on TLC aluminum plates precoated with silica gel 60F-254 using chloroform-methanol (9.0:1.0 v/v) as mobile phase. The densitometric analysis was carried out at 366 nm wavelength. Compact spots appeared at Rf = 0.34 ± 0.02. For the proposed procedure, linearity (r 2 = 0.9956 ± 0.0015), limit of quantification (28.35 ng spot -1 ), limit of detection (9.41 ng spot -1 ) recovery (97.06 -99.56%), and precision (≤1.86) were found to be satisfactory. TBS was subjected to acid and alkali hydrolyses, oxidation and photodegradation treatments. The degraded products were well separated from the pure drug. Statistical analysis reveals that the developed method has potential for routine analysis and stability testing of terbutaline sulfate in pharmaceutical drug delivery systems.
introduction
Terbutaline sulfate (TBS); β-[(tert-butylamino) methyl]-3,5-dihydroxy-benzyl alcohol (C12H19NO3) is a synthetic β2-adrenoceptor (β2AR) stimulant that is widely used as a bronchodilator, mainly in respiratory medicine in the treatment of bronchial asthma, chronic bronchitis, emphysema and related disorders.
1,2 A literature survey revealed that various analytical methods have been reported for the estimation of TBS; they include UV spectroscopy, 3, 4 voltametery, 5, 6 capillary electrophoresis, [7] [8] [9] chemiluminescence, [10] [11] [12] high performance liquid chromatography (HPLC), 1, 13, 14 HPLC-fluorescence detection, 15 HPLC-electrochemical detection, 16 ,17 HPLC-chemiluminescence detection, 18 RP-liquid chromatography, 19 LC-electrochemical detection, 20 column-switching LC, 21 LC-tandem mass spectrometry, 22, 23 and high-resolution GC-mass spectrometry analysis. 24 For TBS pharmacokinetic studies, the most useful analytical method is GC-mass spectrometry. 2, 25, 26 Isolation of unchanged compounds and metabolites from biological samples by GC-MS necessitates elimination of matrix interferences by liquid-liquid extraction, 27 solid phase extraction 28, 29 or both. 24 Recently, electrospray high-field asymmetric waveform ion mobility spectrometry-mass spectrometry (ESI-FAIMS-MS) 30 has been reported as a new approach to chiral separation of TBS enantiomers. According to some researchers, derivatization has an important role in the detection of TBS, 31 usually trimethylsilylation is the standard procedure for this purpose. [24] [25] [26] [27] However to our knowledge, there has been no work reported in the literature about the HPTLC analysis of TBS in either biological fluids or pharmaceutical formulations. HPTLC has advantages over other methods because of rapidity, selectivity, economy and overall versatility in QC aspects of drugs. 32 An ideal-stability indicating method is one that quantifies the drug per se and also resolves its degradation products. Hence we attempted to develop an economic, specific, reproducible and stability-indicating HPTLC method for the determination of TBS in the presence of degradation products and related impurities from a pharmaceutical formulation in the form of submicronized dry powder inhalers (micro-DPIs) and to establish validation as per ICH guidelines.
experimental

Reagents and chemicals
Terbutaline sulfate was received as a gift sample from Jubilant Organosys, Noida, India. All chemicals and reagents used were of analytical grade and were purchased from Merck (Mumbai, India).
Apparatus and chromatographic conditions
Chromatography was performed same as described in our previous findings. 32 In brief, precoated silica gel aluminum plates 60F254 (20 cm × 10 cm, 200 µm thickness; E. Merck, Darmstad, Germany) were used as stationary phase. Samples were spotted in the form of distinct bands (4 mm in width; 10 mm apart) with a CAMAG 100 µL syringe using a Linomat V (CAMAG, Muttenz, Switzerland) sample applicator. Equipment parameters were optimized for smooth working (constant application rate: 160 nL s -1 ; slit dimension: 3 mm × 0.45 mm; and scanning speed: 20 mm s -1 ). Linear ascending development was carried out in a 20 cm × 10 cm twin trough glass chamber (CAMAG, Muttenz, Switzerland), previously saturated with optimized mobile phase for 15 min at room temperature (25 ± 2 C) and relative humidity (RH) of 60 ± 5%. The development includes band space of 10 mm, chromatogram run of 8 cm, 20 mL of mobile phase and time duration of 10 min.
The mobile phase was chloroform-methanol (9.0:1.0 v/v) with densitometric analysis at 366 nm in florescent mode with CAMAG TLC scanner III; a tungsten lamp was used as a radiation source and the procedure were operated by winCATS software (Ver. 1.2.0).
Stock solution and QC samples
A stock solution of TBS (100 ng µL
) was prepared in methanol. Different volumes of stock solution ranging from 1 -10 µL -1 were spotted in triplicate on TLC plates to obtain a final concentration range of 100 -1000 ng spot -1 . The data of peak areas plotted against corresponding concentration were treated by linear-square regression. QC samples were prepared at concentrations of 400 and 800 ng spot -1 .
Method validation
Precision and accuracy. The intra-day precision and accuracy of the assays was evaluated by performing replicate analyses (n = 6) of QC samples (200, 400 and 800 ng spot -1 ). The inter-day precision and accuracy of the assay was determined by repeating the intra-day assay on three different days. Precision was expressed as the percentage coefficient variation (CV, %) of measured concentrations for each calibration level, whereas accuracy was expressed as percent recovery (TBS found/TBS applied) × 100). Robustness of the method. After introducing small changes in optimized mobile phase system compositions, mobile phase volume and duration of mobile phase saturation, we observed the effects on the results. Mobile phases having different compositions of chloroform-methanol (8.75:1.25 and 9.25:0.75 v/v) were tried for one QC sample (800 ng spot -1 ) and chromatograms were run. Mobile phase volume and duration of saturation were varied at 20 ± 2 mL (18, 20 and 22) and 30 ± 10 min (20, 30 and 40 min), respectively. Robustness of the method was studied in triplicate at a concentration level of 800 ng spot -1 . Sensitivity and linearity. In order to estimate detection (LOD) and quantification (LOQ) limits, we spotted blank methanol (n = 6) following the same method as explained under the Section Apparatus and chromatographic conditions and the standard deviation (σ) of the magnitude of analytical response was determined. The LOD was expressed as (LOD = 3.3σ/slope of TBS calibration curve), whereas LOQ was expressed as (LOQ = 10σ/slope of TBS calibration curve). Recovery studies. Recovery studies for the method were carried out by applying the method to drug samples to which known amounts of TBS corresponding to 50, 100 and 150% of the TBS label claim had been added. At each level of the amount, six determinations were performed. This was done to check for the recovery of the drug at different levels in the formulations.
Analysis of submicronized terbutaline sulfate particles (micro-TBS)
To determine the content of micro-TBS (labeled claim: 25 mg), we measured dry powder equivalent to 25 mg of TBS. For complete extraction of the drug, it was sonicated for 30 min and the volume was then made up to 100 mL. The resulting solution was centrifuged at 15000 rpm for 30 min and the supernatant was analyzed for drug content. Two microliters (500 ng spot -1 ) of the above solution was spotted onto the plate followed by development and scanning as described in the Section on Apparatus and chromatographic conditions. The analysis was repeated three times. The possibility of excipient interference in the analysis was studied.
Forced degradation studies
A stock solution containing 50 mg of TBS and submicronized dry powder (micro-TBS) equivalent to 50 mg of TBS was separately prepared in 50 mL methanol. The stock solution (1000 µg mL -1 ) was used for forced degradation to provide an indication of the stability-indicating property and the specificity of the proposed method. Acid and base induced degradation product. To 5 mL of methanolic stock solutions (TBS and micro-TBS), 5 mL of 2 N HCl (acid) and 2 N NaOH (alkali) was added and the resultant mixtures were refluxed separately for 3 h at 80 C in the dark (to exclude the possible degradative effect of light). Two microliters (1000 ng spot -1 ) of the resultant solutions were carefully applied on the TLC plate and the chromatograms were run as described in the Section Apparatus and chromatographic conditions. The average peak area for TBS after application (1000 ng spot -1 ) of six replicates was obtained. Hydrogen-peroxide induced degradation product. Again, to 5 mL of methanolic stock solutions of TBS and micro-TBS (equivalent to 50 mg of TBS), 5 mL of hydrogen peroxide (H2O2; 30.0%, v/v) were added separately. The solutions were gently heated in a boiling water bath for 20 min and then refluxed for 3 h at 80 C to remove excess hydrogen peroxide. Two Microliters (1000 ng spot -1 ) of the resultant solutions were spotted on the TLC plate and the chromatograms were run as described in the Section on Apparatus and chromatographic conditions. The average peak area for TBS after application (1000 ng spot -1 ) of six replicates was obtained. Photochemical induced degradation product. To 5 mL of methanolic stock solutions of (TBS and micro-TBS) equivalent to 50 mg of TBS, 5 mL of methanol was added and the solution was exposed to direct sunlight for 3 consecutive days (GMT: 09:00 -17:00 h at 30 C; total 24 h) and UV irradiation at 254 nm for 8 h in a UV chamber.
Two Microliters (1000 ng spot -1 ) of the resultant solutions were applied on the TLC plate and the chromatograms were run as described in the Section on Apparatus and chromatographic conditions. The average peak area for TBS after application (1000 ng spot 
results and discussion
Mobile phase optimization
Our TLC procedure was optimized to develop a stability-indicating assay method to quantify submicronized TBS. Initially chloroform and methanol in varying ratios were tried. The mobile phase chloroform-methanol in ratio of 8.75:1.25 (v/v); gave slightly diffused spots and therefore included a slight variation in polarity. When the ratio varied as chloroform-methanol (9.25:0.75 v/v) gave good resolution with Rf value of 0.34 for TBS but typical peak nature was missing due to tailing of the spot. Finally, the mobile phase consisting of chloroform-methanol (9.0:1.0 v/v) gave a sharp and well-defined peak at Rf value of 0.34. Table 1 summarizes the intra-and inter-day precision, as coefficient of variation (CV; %) and accuracy of the assay determined at TBS concentration of 200, 400 and 800 ng spot -1 . The intra-day precision (n = 6) was ≤ 1.86%. The inter-day precision over three different days was ≤ 2.31%. The intra-day and inter-day accuracy were in the range of 99.30 -100.63 and 98.09 -99.29%, respectively. The repeatability of the method was studied by assaying six samples of submicronized DPIs at same concentration under the same experimental conditions and the coefficient of variation was found to be 0.89. The values were within the acceptable range and so we concluded that the method was accurate, reliable and reproducible. Robustness of the method. Table 2 describes the robustness of the proposed method. The % RSD of the peak areas was calculated for the change in mobile phase composition, mobile phase volume, duration of saturation and activation of prewashed-TLC plates at a concentration level of 800 ng spot -1 in triplicate. The low values of SD (<3.0) and % RSD (<1.2) obtained after introducing small deliberate changes in the developed HPTLC method indicated the robustness of the method. There was no significant variation in the slope values (ANOVA; P > 0.05). Linearity and sensitivity. Under the described chromatographic conditions, TBS was well resolved at Rf 0.34 ± 0.02. The linear regression data for the calibration curves of TBS (n = 6) showed a good linear relationship (correlation coefficient, r 2 = 0.9956 ± 0.0015) over the concentration range 100 -1000 ng spot -1 with respect to the peak area. The coefficient of variations of slope for TBS was found to be lower than 5%, which indicates a high precision of the assay. LOD and LOQ determined by the standard deviation method were found to be 9.41 and 28.35 ng spot -1 respectively, indicating adequate assay sensitivity of the proposed method. Recovery studies. The proposed method, when used for estimation of TBS after spiking with 50, 100 and 150% of additional drug, afforded recovery ranging from 97.06 -99.56% for submicronized terbutaline sulfate particles (micro-TBS) as listed in Table 3 . The RSD of recovery micro-TBS was in the range 0.86 -1.44. The absence of interference peaks of degradation products, impurities and excipients indicate the specificity of the method.
Method validation Precision and accuracy.
Analysis of submicronized terbutaline sulfate particles (micro-TBS)
A single spot at Rf 0.34 was observed in the chromatogram of the micro-TBS extracted samples. There was no interference from the excipients present in formulation. The TBS content was found to be 97.85% with a %RSD of 1.3. It may therefore be inferred that degradation of TBS had not occurred in the formulations that were analyzed by this method. The low %RSD value indicated the suitability of this method for routine analysis of TBS in pharmaceutical dosage forms.
Forced degradation studies
Acid and Base induced degradation products. Drug recovery at the level of 54.53% and 49.70% from the acid-stressed samples for TBS and micro-TBS (Figs. 1a and 1b) , suggests significant (P < 0.05) degradation of TBS in acidic conditions (Table 4) . However drug recovery from base-stressed sample for both TBS and micro-TBS (Figs. 2a and 2b ) afforded 96.14% and 94.36, signifying little degradation of TBS in alkaline media (Table 4) . The chromatogram of acid-degraded samples of TBS showed four additional peaks at Rf values of 0.09, 0.25, 0.54 and 0.61 (Fig. 1a) ; however, three additional peaks appeared at Rf values of 0.20, 0.54 and 0.62 as degradants in micro-TBS (Fig. 1b) . Chromatograms of base degraded samples appeared when subjected to alkaline degradation of TBS as well as micro-TBS (Figs. 3a and 3b) . The chromatogram of base-degraded samples a. Mean of six determinations (n = 6). b. Precision as coefficient of variation (CV, %) = standard deviation divided by concentration found × 100. c. Accuracy = concentration found/nominal concentration × 100. (Fig. 2a) ; however, three additional peaks emerged at Rf values of 0.14, 0.27 and 0.36 as degradants in micro-TBS solution (Fig. 2b) . The different Rf values obtained from acid-treated samples and from base-treated samples indicate that acid degradation products are different from alkaline degradation products.
Hydrogen-peroxide induced degradation products. The chromatogram of the sample of TBS and micro-TBS treated with 30% (v/v) H2O2 showed no peak ( Table 4 ), suggesting that terbutaline sulfate (TBS) is liable to get completely oxidized in this condition. No drug recovery was found for both TBS and micro-TBS signifying complete degradation of TBS.
Photochemical degradation products. Drug recovery at the level of 94.82 and 93.91% (Figs. 4a and 4b) for the UV254 nm-exposed samples respectively for TBS and micro-TBS suggests significant (P < 0.05) degradation of TBS in these conditions. However when exposed to sunlight drug recovery levels were 96.46 and 95.61% (Figs. 3a and 3b) respectively for TBS as well as micro-TBS, such results reveal its susceptibility towards UV irradiation than to sunlight degradation. The UV light-treated TBS samples provided two additional peaks at Rf values of 0.30 and 0.65 (Fig. 4a) and three additional peaks for micro-TBS at Rf values of 0.04, 0.06 and 0.44 ( Fig. 4b and Table 4 ). The sunlight-degraded samples, however, showed two additional peaks at Rf values of 0.35 and 0.48 for TBS (Fig. 3a) and one additional peak at Rf = 0.53 for micro-TBS (Fig. 3b and Table 4 ). 
